Ancestral Mutation in Telomerase Causes Defects in Repeat Addition Processivity and Manifests As Familial Pulmonary Fibrosis
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The telomerase reverse transcriptase synthesizes new telomeres onto chromosome ends by copying from a short template within its integral RNA component. During telomere synthesis, telomerase adds multiple short DNA repeats successively, a property known as repeat addition processivity. However, the consequences of defects in processivity on telomere length maintenance are not fully known. Germline mutations in telomerase cause haploinsufficiency in syndromes of telomere shortening, which most commonly manifest in the age-related disease idiopathic pulmonary fibrosis. We identified two pulmonary fibrosis families that share two non-synonymous substitutions in the catalytic domain of the telomerase reverse transcriptase gene hTERT: V791I and V867M. The two variants fell on the same hTERT allele and were associated with telomere shortening. Genealogy suggested that the pedigrees shared a single ancestor from the nineteenth century, and genetic studies confirmed the two families had a common founder. Functional studies indicated that, although the double mutant did not dramatically affect first repeat addition, hTERT V791I-V867M showed severe defects in telomere repeat addition processivity in vitro. Our data identify an ancestral mutation in telomerase with a novel loss-of-function mechanism. They indicate that telomere repeat addition processivity is a critical determinant of telomere length and telomere-mediated disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, both dyskeratosis congenita and IPF patients are prone to developing haematological malignancies, commonly manifesting as myelodysplasia or acute myeloid leukaemia70,75,76.”
From The telomere syndromes (2012) · cites this paper as [76]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 1×
“Telomerase is a specialized DNA polymerase that synthesizes new telomere repeats onto chromosome ends [1,2].”
BackgroundMerlin—rapid analysis of dense genetic maps using sparse gene flow trees
Abecasis, G. R., Cherny, S. S., Cookson, W. O., & Cardon, L. R. (2002) · Nature Genetics · doi:10.1038/ng786 · Cited by 3,354 · cited 1×
“We used Merlin to calculate a single point LOD score [44], under the assumption of autosomal dominant inheritance and a 1/10,000 population frequency of idiopathic interstitial lung disease.”
MethodThe RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · cited 1×
“Telomerase has two essential conserved components, a catalytic reverse transcriptase, hTERT, and an RNA component, hTR [3,4].”
BackgroundA telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643 · cited 1×
“The RNA component of telomerase contains a template sequence for the addition of new telomere repeats [5].”
BackgroundObesity, cigarette smoking, and telomere length in women
Valdes, A., Andrew, T., Gardner, J., Kimura, M., Oelsner, E., Cherkas, L., Aviv, A., & Spector, T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66630-5 · Cited by 1,363 · cited 1×
“risk of both emphysema and pulmonary fibrosis [39], it is”
BackgroundTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 10×
“At standard assay conditions of 1 mM nucleotide concentrations [8,12,13,20,27], the 791I alone did not have obvious defects in activity or processivity (Figure 3A, lane 3).”
BackgroundMethodInfluentialSelf-citationReverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269 · cited 2×
“Telomerase has two essential conserved components, a catalytic reverse transcriptase, hTERT, and an RNA component, hTR [3,4].”
BackgroundHemann, M. T., Strong, M. A., Hao, L.-Y., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00504-9 · Cited by 1,219 · cited 1×
“Telomerase preferentially elongates the shortest telomeres [41,42], and our functional studies which show intact single repeat synthesis, point to the fact that the ancestral hTERT 791I-867M may have the capacity to add initial telomere tracts, thus healing the shortest telomeres.”
BackgroundGreider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150 · cited 1×
“Telomerase is a specialized DNA polymerase that synthesizes new telomere repeats onto chromosome ends [1,2].”
Background
Cited by
Armanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982
Self-citationTelomeres and age-related disease: how telomere biology informs clinical paradigms
Armanios, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66370 · Cited by 347
“IPF presents at a mean age between 50 and 60 years (range 31–87) (35, 45, 47, 51, 59, 60), and telomere-related cryptogenic liver fibrosis, based on reported cases, presents at a mean of 37 years (range 20–57) (12, 59, 61).”
Self-citationBone marrow failure and the telomeropathies
Townsley, D. M., Dumitriu, B., & Young, N. S. (2014) · Blood · doi:10.1182/blood-2014-05-526285 · Cited by 291
Diagnostic utility of telomere length testing in a hospital-based setting
Alder, J. K., Hanumanthu, V. S., Strong, M. A., DeZern, A. E., Stanley, S. E., Takemoto, C. M., Danilova, L., Applegate, C. D., Bolton, S. G., Mohr, D. W., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720427115 · Cited by 268
Self-citationTelomere Length Is a Determinant of Emphysema Susceptibility
Alder, J. K., Guo, N., Kembou, F., Parry, E. M., Anderson, C. J., Gorgy, A. I., Walsh, M. F., Sussan, T., Biswal, S., Mitzner, W., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0520oc · Cited by 265
Self-citationDiseases of Pulmonary Surfactant Homeostasis
Whitsett, J. A., Wert, S. E., & Weaver, T. E. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104644 · Cited by 256
Modeling of fibrotic lung disease using 3D organoids derived from human pluripotent stem cells
Strikoudis, A., Cieślak, A., Loffredo, L., Chen, Y.-W., Patel, N., Saqi, A., Lederer, D. J., & Snoeck, H.-W. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.077 · Cited by 242
Telomerase and idiopathic pulmonary fibrosis
Armanios, M. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.10.013 · Cited by 245
“The requirement for additional hits may explain why mutant telomerase genes in IPF patients manifest late in life where the average age of onset is in the sixth decade[26, 42, 43].”
BackgroundSelf-citationGenetics of human telomere biology disorders
Revy, P., Kannengiesser, C., & Bertuch, A. A. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00527-z · Cited by 234
Stanley, S. E., Gable, D. L., Wagner, C. L., Carlile, T. M., Hanumanthu, V. S., Podlevsky, J. D., Khalil, S. E., DeZern, A. E., Rojas-Duran, M. F., Applegate, C. D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7837 · Cited by 210
Self-citationAmnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair
Tan, J. L., Lau, S. N., Leaw, B., Nguyen, H. P. T., Salamonsen, L. A., Saad, M. I., Chan, S. T., Zhu, D., Krause, M., Kim, C., et al. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0185 · Cited by 206
Telomerase mutations in smokers with severe emphysema
Stanley, S. E., Chen, J. J. L., Podlevsky, J. D., Alder, J. K., Hansel, N. N., Mathias, R. A., Qi, X., Rafaels, N. M., Wise, R. A., Silverman, E. K., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78554 · Cited by 196
Self-citationDressen, A., Abbas, A. R., Cabanski, C., Reeder, J., Ramalingam, T. R., Neighbors, M., Bhangale, T. R., Brauer, M. J., Hunkapiller, J., Reeder, J., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30135-8 · Cited by 196
Parry, E. M., Alder, J. K., Qi, X., Chen, J. J.-L., & Armanios, M. (2011) · Blood · doi:10.1182/blood-2010-11-322149 · Cited by 194
Self-citationLung transplantation in telomerase mutation carriers with pulmonary fibrosis
Silhan, L. L., Shah, P. D., Chambers, D. C., Snyder, L. D., Riise, G. C., Wagner, C. L., Hellström-Lindberg, E., Orens, J. B., Mewton, J. F., Danoff, S. K., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00060014 · Cited by 192
Self-citationThe pathogenesis of COPD and IPF: Distinct horns of the same devil?
Chilosi, M., Poletti, V., & Rossi, A. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-3 · Cited by 183
“expression of senescence-related cell-cycle regulators (p21 and p16 )[19,25,34,35].”
Lung cancer in patients with idiopathic pulmonary fibrosis
Karampitsakos, T., Tzilas, V., Tringidou, R., Steiropoulos, P., Aidinis, V., Papiris, S. A., Bouros, D., & Tzouvelekis, A. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.03.016 · Cited by 171
“Telomerase mutations carriers are more susceptible to IPF development (78, 79) and patients with IPF and telomerase mutations are more prone to severe posttransplant complications (80).”
BackgroundMitochondria, telomeres and cell senescence: Implications for lung ageing and disease
Birch, J., Barnes, P. J., & Passos, J. F. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.005 · Cited by 170
“…dubbed a ‘disease of ageing’ but contrastingly is characterised by fibrosis of the interstitium, leading to scarring of the lung parenchyma, with limited airway-centered pathology (Alder et al., 2008; Alder et al., 2011; Minagawa et al., 2011; Raghu, Weycker, Edelsberg, Bradford, & Oster, 2006).”
BackgroundThe molecular genetics of the telomere biology disorders
Bertuch, A. A. (2016) · RNA Biology · doi:10.1080/15476286.2015.1094596 · Cited by 169
“,.(74,89) Strikingly, however, Zaug et al.”
It all comes together at the ends: Telomerase structure, function, and biogenesis
Podlevsky, J. D., & Chen, J. J.-L. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.11.002 · Cited by 144
Self-citationTelomere-mediated lung disease
Alder, J. K., & Armanios, M. (2022) · Physiological Reviews · doi:10.1152/physrev.00046.2021 · Cited by 130
Self-citationEuropean Respiratory Society statement on familial pulmonary fibrosis
Borie, R., Kannengiesser, C., Antoniou, K. M., Bonella, F., Crestani, B., Fabre, A., Froidure, A., Galvin, L., Griese, M., Grutters, J. C., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01383-2022 · Cited by 147
“This inheritance explains the phenomenon of genetic anticipation, which is defined as an earlier and more severe disease with each generation (figure 1) [34, 93, 127, 128].”
BackgroundTelomere DNA G-quadruplex folding within actively extending human telomerase
Jansson, L. I., Hentschel, J., Parks, J. W., Chang, T. R., Lu, C. C., Baral, R., Bagshaw, C. R., & Stone, M. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814777116 · Cited by 138
The Role of Telomeres in Human Disease
Armanios, M. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-010422-091101 · Cited by 126
“In half of the cases, heterozygous mutations in TERT are the culprit, and these autosomal dominant–inherited mutations show genetic anticipation in families (an earlier and more severe onset of disease across generations) (4, 20, 72).”
BackgroundSelf-citationThe short and long telomere syndromes: paired paradigms for molecular medicine
Stanley, S. E., & Armanios, M. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.06.004 · Cited by 124
“The rate of genetic anticipation and disease evolution within a family depends on the extent of telomere shortening caused by a given mutant allele across a generation [72].”
Self-citationPardo, A., & Selman, M. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0373ps · Cited by 117
FBW7 Mediates Senescence and Pulmonary Fibrosis through Telomere Uncapping
Wang, L., Chen, R., Li, G., Wang, Z., Liu, J., Liang, Y., & Liu, J.-P. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.004 · Cited by 109
Alder, J. K., Parry, E. M., Yegnasubramanian, S., Wagner, C. L., Lieblich, L. M., Auerbach, R., Auerbach, A. D., Wheelan, S. J., & Armanios, M. (2013) · Human Mutation · doi:10.1002/humu.22397 · Cited by 102
“Dyskerin functions to stabilize TR, and interacts with TR through an essential Box H/ACA RNA domain in its 3′end [Alder et al., 2011b; Mitchell et al., 1999].”
BackgroundSelf-citationLung epithelial stem cells and their niches: Fgf10 takes center stage
Volckaert, T., & Langhe, S. D. (2014) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-7-8 · Cited by 127
“Widespread damage to the epithelium and/or exhaustion of the epithelial stem cell pool, such as in IPF patients with certain telomerase mutations [142-149], ultimately leads to epithelial loss.”
BackgroundShort Telomere Syndromes in Clinical Practice: Bridging Bench and Bedside
Mangaonkar, A. A., & Patnaik, M. M. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.03.020 · Cited by 98
“IPF, Emphysema, and Interstitial Pneumonitis Idiopathic pulmonary fibrosis is the most frequent pulmonary manifestation seen in patients with STSs (70%) and can occur in the setting of familial IPF (25%) or sporadic IPF (1%-3%).(6,14,15) In addition to IPF, additional pulmonary issues that can be encountered include b…”
Lung Cancer and Interstitial Lung Diseases: A Systematic Review
Archontogeorgis, K., Steiropoulos, P., Τzouvelekis, Α., Nena, E., & Bouros, D. E. (2012) · Pulmonary Medicine · doi:10.1155/2012/315918 · Cited by 97
“The mutations were associated with telomere shortening leading to defects in the repeat addition processivity and contributing to the disease development [20].”
BackgroundThe common ancestral core of vertebrate and fungal telomerase RNAs
Qi, X., Li, Y., Honda, S., Hoffmann, S., Marz, M., Mosig, A., Podlevsky, J. D., Stadler, P. F., Selker, E. U., & Chen, J. J. ‐. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks980 · Cited by 101
“Recently, mutations decreasing telomerase repeat addition processivity have been linked to familial pulmonary fibrosis (3,4).”
BackgroundSelf-citationInfluence of age on wound healing and fibrosis
Kapetanaki, M. G., Mora, A. L., & Rojas, M. (2013) · The Journal of Pathology · doi:10.1002/path.4122 · Cited by 90
Connective tissue diseases, multimorbidity and the ageing lung
Spagnolo, P., Cordier, J.-F., & Cottin, V. (2016) · European Respiratory Journal · doi:10.1183/13993003.00829-2015 · Cited by 95
Management of suspected monogenic lung fibrosis in a specialised centre
Borie, R., Kannengiesser, C., de Fontbrune, F. S., Gouya, L., Nathan, N., & Crestani, B. (2017) · European Respiratory Review · doi:10.1183/16000617.0122-2016 · Cited by 88
Pulmonary fibrosis in the era of stratified medicine
Mathai, S. K., Newton, C. A., Schwartz, D. A., & Garcia, C. K. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-209172 · Cited by 77
Many disease-associated variants of hTERT retain high telomerase enzymatic activity
Zaug, A. J., Crary, S. M., Fioravanti, M. J., Campbell, K. P., & Cech, T. R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt653 · Cited by 82
“In any case, these comparisons do serve to point out one obvious advantage of the direct assay: it gives information about both activity and processivity, whereas the ‘ladder’ of products observed by TRAP is produced by PCR and is not related to enzyme processivity in any simple way (4,46).”
BackgroundPulmonary phenotypes associated with genetic variation in telomere-related genes
Hoffman, T. W., van Moorsel, C. H. M., Borie, R., & Crestani, B. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000475 · Cited by 70
Cutting, C. C., Bowman, W. S., Đao, N. H., Pugashetti, J. V., Garcia, C. K., Oldham, J. M., & Newton, C. A. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.01.026 · Cited by 70
Targeting Alveolar Repair in Idiopathic Pulmonary Fibrosis
Ptasinski, V., Stegmayr, J., Belvisi, M. G., Wagner, D. E., & Murray, L. A. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0476tr · Cited by 65
“Studies assessing the mechanisms by which hTERTmutations may contribute to cases of familial IPF identified two variants, V791I and V867M, that caused defects in telomere repeat addition processivity in vitro (67).”
BackgroundZhang, D., & Newton, C. A. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.037 · Cited by 72
Human telomerase specialization for repeat synthesis by unique handling of primer‐template duplex
Wu, R. A., & Collins, K. (2014) · The EMBO Journal · doi:10.1002/embj.201387205 · Cited by 66
“…of human telomerase RAP induces telomere shortening (Pascolo et al, 2002), some disease-associated human TERT mutations primarily affect RAP (Robart & Collins, 2010; Alder et al, 2011), and engineered yeast and human TERTs with decreased RAP do not support telomere maintenance (Wyatt et al, 2010).”
BackgroundPredictive factors and prognostic effect of telomere shortening in pulmonary fibrosis
Planas‐Cerezales, L., Arias‐Salgado, E. G., Buendía-Roldán, I., Montes‐Worboys, A., Esquinas, C., Vicens‐Zygmunt, V., Hernaiz, P. L., Sanuy, R. L., Leiro‐Fernández, V., Balcells, E., et al. (2018) · Respirology · doi:10.1111/resp.13423 · Cited by 63
Borie, R., Kannengiesser, C., Nathan, N., Tabèze, L., Pradère, P., & Crestani, B. (2014) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2014.07.017 · Cited by 59
Molecular mechanisms of ageing and related diseases
Liu, J. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12247 · Cited by 56
Tsang, A. R., Wyatt, H. D. M., Ting, N. S. Y., & Beattie, T. L. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00810.x · Cited by 46
“It has recently been reported that another IPF associated hTERT mutation, V867M, also displayed defects in RAP (Alder et al., 2011).”
BackgroundRegulated assembly and disassembly of the yeast telomerase quaternary complex
Tucey, T. M., & Lundblad, V. (2014) · Genes & Development · doi:10.1101/gad.246256.114 · Cited by 49
“For example, amultigenerational germline mutation in hTERT (encoding the telomerase reverse transcriptase component) that attenuates one aspect of telomerase enzymatic activity confers a progressive decline in lung function late in life (Alder et al. 2011).”
BackgroundGenetic susceptibility and pulmonary fibrosis
Mathai, S. K., Schwartz, D. A., & Warg, L. A. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000074 · Cited by 39
Gramatges, M. M., Qi, X., Sasa, G., Chen, J. J. ‐., & Bertuch, A. A. (2013) · Blood · doi:10.1182/blood-2012-08-447755 · Cited by 43
“Recently, 2 families with an ancestral TERT mutation were reported as having a predominantly adult-onset pulmonary fibrosis phenotype over multiple generations, with only 4 of 18 mutation carriers developing other characteristics of a telomere biology disorder, such as subclinical cytopenias, liver function abnormalit…”
BackgroundInfluentialSelf-citationInsights from human genetic studies of lung and organ fibrosis
Garcia, C. K. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93556 · Cited by 40
“After 3 to 9 months, deletion of TRF1 from rare variants lead to alterations in protein function, as measured by decreased telomerase catalytic activity (18, 19, 27), decreased telomerase processivity (28), increased aberrant T-circle formations (21), and short telomere lengths (3, 18, 19, 21, 22, 23–27).”
BackgroundHong, X., Wang, L., Zhang, K., Liu, J., & Liu, J. (2022) · Cells · doi:10.3390/cells11050877 · Cited by 38
Telomerase and Telomeres in Endometrial Cancer
Alnafakh, R., Adishesh, M., Button, L., Saretzki, G. C., & Hapangama, D. K. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00344 · Cited by 64
van Batenburg, A. A., Kazemier, K. M., van Oosterhout, M. F. M., van der Vis, J. J., Grutters, J. C., Goldschmeding, R., & van Moorsel, C. H. M. (2021) · ERJ Open Research · doi:10.1183/23120541.00691-2020 · Cited by 40
Aschner, Y., Khalifah, A. P., Briones, N. J., Yamashita, C. M., Dolgonos, L., Young, S. K., Campbell, M., Riches, D. W. H., Redente, E. F., Janssen, W. J., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.01.016 · Cited by 34
van Batenburg, A. A., Kazemier, K. M., van Oosterhout, M. F. M., van der Vis, J. J., van Es, H. W., Grutters, J. C., Goldschmeding, R., & van Moorsel, C. H. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226785 · Cited by 34
Pulmonary Fibrosis and a TERT Founder Mutation With a Latency Period of 300 Years
van der Vis, J. J., van der Smagt, J. J., Hennekam, F. A. M., Grutters, J. C., & van Moorsel, C. H. M. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.03.069 · Cited by 32
Multiple genetic pathways regulate replicative senescence in telomerase‐deficient yeast
Ballew, B. J., & Lundblad, V. (2013) · Aging Cell · doi:10.1111/acel.12099 · Cited by 32
“…illustrated by the spectrum of age-dependent characteristics displayed by individuals who have an identical genetically inherited defect in telomerase (Alder et al., 2011), which suggests that telomere shortening in telomerase-depleted cells may be subject to a complex pattern of genetic control.”
BackgroundA single nucleotide incorporation step limits human telomerase repeat addition activity
Chen, Y., Podlevsky, J. D., Logeswaran, D., & Chen, J. J. ‐. (2018) · The EMBO Journal · doi:10.15252/embj.201797953 · Cited by 34
“…been identified telomerase mutations which impair specifically repeat addition processivity and not catalytic activity, yet result in stem cell defects that manifest as a spectrum of short telomere syndromes (Robart & Collins, 2010; Alder et al , 2011; Gramatges et al , 2013; Zaug et al , 2013).”
Self-citation2.7 Å cryo-EM structure of human telomerase H/ACA ribonucleoprotein
Ghanim, G. E., Sekne, Z., Balch, S., van Roon, A. M., & Nguyen, T. H. D. (2024) · Nature Communications · doi:10.1038/s41467-024-45002-x · Cited by 35
Pulmonary fibrosis in non‐mutation carriers of families with short telomere syndrome gene mutations
van der Vis, J. J., van der Smagt, J. J., van Batenburg, A. A., Goldschmeding, R., van Es, H. W., Grutters, J. C., & van Moorsel, C. H. M. (2021) · Respirology · doi:10.1111/resp.14145 · Cited by 29
“and by Alder et al.(36,37) This, together with our findings, shows a pattern where in predictive genetic testing the absence of the TRG mutation does not exclude the risk for disease.”
BackgroundRegulation of telomere length and homeostasis by telomerase enzyme processivity
D’Souza, Y., Lauzon, C., Chu, T. W., & Autexier, C. (2012) · Journal of Cell Science · doi:10.1242/jcs.119297 · Cited by 28
“Secondly, an ancestral mutation in telomerase (V791I-V867M) found in patients with familial pulmonary fibrosis causes defects in processivity and is associated with telomere shortening (Alder et al., 2011).”
BackgroundThe importance of matrix metalloproteinase-3 in respiratory disorders
Yamashita, C. M., Radisky, D. C., Aschner, Y., & Downey, G. P. (2014) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.909288 · Cited by 27
Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma
Donaires, F. S., Scatena, N. F., Alves‐Paiva, R. M., Podlevsky, J. D., Logeswaran, D., Santana, B. A., Teixeira, A. C., Chen, J. J. ‐., Calado, R. T., & Martinelli, A. D. L. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183287 · Cited by 27
Self-citationTelomeres: Dysfunction, Maintenance, Aging and Cancer
Liao, P., Yan, B., Wang, C., & Lei, P. (2023) · Aging and Disease · doi:10.14336/ad.2023.1128 · Cited by 36
Familial Interstitial Lung Disease
Kropski, J. A. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1708054 · Cited by 23
Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction
Planas‐Cerezales, L., Arias‐Salgado, E. G., Berastegui, C., Montes‐Worboys, A., González‐Montelongo, R., Lorenzo-Salazar, J. M., Vicens‐Zygmunt, V., Garcia-Moyano, M., Dorca, J., Flores, C., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.695919 · Cited by 30
Borie, R., Kannengiesser, C., & Crestani, B. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328356b15c · Cited by 22
Tesmer, V. M., Smith, E. M., Danciu, O. C., Padmanaban, S., & Nandakumar, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911912116 · Cited by 21
“F. Wang et al., The POT1-TPP1 telomere complex is a telomerase processivity factor.”
BackgroundInfluentialShall we call them “telomere-mediated”? Renaming the idiopathic after the cause is found
Merck, S. J., & Armanios, M. Y. (2016) · European Respiratory Journal · doi:10.1183/13993003.02115-2016 · Cited by 18
Self-citationCalado, R. T. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00008-6 · Cited by 20
“Telomere attrition also has been associated with combined pulmonary fibrosis and emphysema syndrome.(6,7)”
BackgroundGenetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective
Papiris, S. A., Kannengiesser, C., Borie, R., Kolilekas, L., Kallieri, M., Apollonatou, V., Ba, I., Nathan, N., Bush, A., Griese, M., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12122928 · Cited by 20
“Elaborate genealogical research studies have shown that a latency period of >300 years may pass before the cumulative effect of telomere shortening eventually leads to familial PF in TRG mutation carriers [141,155].”
BackgroundSubclinical liver fibrosis in patients with idiopathic pulmonary fibrosis
Cocconcelli, E., Tonelli, R., Abbati, G., Marchioni, A., Castaniere, I., Pelizzaro, F., Russo, F. P., Vegetti, A., Balestro, E., Pietrangelo, A., et al. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02376-2 · Cited by 17
The Role of Ubiquitination and SUMOylation in Telomere Biology
Zalzman, M., Meltzer, W. A., Portney, B. A., Brown, R. A., & Gupta, A. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.035.085 · Cited by 18
“to cancer, as patients with telomere related diseases have an increased risk for developing cancer (de la Fuente and Dokal, 2007; Alter et al., 2009; Diaz de Leon et al., 2010; Alder et al., 2011).”
BackgroundD’Souza, Y., Chu, T. W., & Autexier, C. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-12-0889 · Cited by 15
“An ancestral mutation in hTERT, V867M-V791I, leading to decreased RAP, was previously shown to correlate with the development of idiopathic pulmonary fibrosis in members of two families (Alder et al., 2011).”
BackgroundBorie, R., Kannengiesser, C., Dupin, C., Debray, M., Cazes, A., & Crestani, B. (2020) · La Presse Médicale · doi:10.1016/j.lpm.2020.104024 · Cited by 13
Shah, P. D., & Armanios, M. Y. (2025) · European Respiratory Journal · doi:10.1183/13993003.01545-2024 · Cited by 12
“They compromise telomerase abundance, recruitment and function [1, 14].”
Self-citationISHLT Consensus Statement on Short Telomere Syndrome and Lung Transplantation
Courtwright, A., Mackintosh, J. A., Alder, J. K., Garcia, C. K., Froidure, A., Lowery, E. M., Hayes, D., Pali, S., Philippot, Q., Borie, R., et al. (2026) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2025.10.028 · Cited by 12
Self-citationTomlinson, C. G., Holien, J. K., Mathias, J. A. T., Parker, M. W., & Bryan, T. M. (2016) · Biochimie · doi:10.1016/j.biochi.2016.07.010 · Cited by 11
Dyskeratosis Congenita and the Telomere Biology Disorders
Dodson, L. M., & Bertuch, A. A. (2018) · Pediatric oncology · doi:10.1007/978-3-319-61421-2_6 · Cited by 8
Niaz, A., Truong, J. Q., Manoleras, A., Fox, L. C., Blombery, P. A., Vasireddy, R. S., Pickett, H. A., Curtin, J. A., Barbaro, P., Rodgers, J., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007029 · Cited by 9
“A different variant in hTERT that reduces telomerase processivity by 50% has been reported to be sufficient for telomere shortening in vivo and familial pulmonary fibrosis when inherited heterozygously.(77) Therefore, although coexpression of K1050E and WT telomerase appeared to largely rescue the processivity defect…”
Xu, H., Gong, X., Zhang, H. H., Zhang, Q., Zhao, D., & Peng, J. X. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.24343 · Cited by 8
Deshpande, A. P., & Collins, K. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky601 · Cited by 10
Cellular plasticity and regenerative mechanisms in the lung
Zaragosi, L., Salwig, I., Wasnick, R. M., Lehmann, M., & Pardo–Saganta, A. (2026) · European Respiratory Review · doi:10.1183/16000617.0168-2025 · Cited by 8
Adaptive and Maladaptive Clonal Hematopoiesis in Telomere Biology Disorders
Lasho, T., & Patnaik, M. M. (2024) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-023-00719-2 · Cited by 7
“Mutations in TERT are most prevalent and account for up to 50% of cases [83–85].”
Genomic Fingerprint Associated with Familial Idiopathic Pulmonary Fibrosis: A Review
Ding, D., Gao, R., Xue, Q., Luan, R., & Yang, J. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.80358 · Cited by 8
“This is followed by successive generations with increased symptoms of an earlier onset (52).”
BackgroundRaykov, V., Marvin, M. E., Louis, E. J., & Maringele, L. (2016) · Genetics · doi:10.1534/genetics.115.183020 · Cited by 7
“Telomeres shorten prematurely in certain diseases and genetic syndromes, for example, liver cirrhosis, pulmonary fibrosis, and dyskeratosis congenita (Alder et al. 2011; Batista et al. 2011; El-Chemaly et al. 2011).”
BackgroundFueling the fire: metabolic dysfunction and senescence as drivers of lung aging and disease
Kliment, C. R., Gurkar, A. U., Cárdenes, N., Ramonell, R. P., Finkel, T., & Königshoff, M. (2026) · Physiological Reviews · doi:10.1152/physrev.00024.2025 · Cited by 7
A persistent variant telomere sequence in a human pedigree
Hinchie, A. M., Sanford, S. L., Loughridge, K. E., Sutton, R. M., Parikh, A. H., Silva, A. A. G., Sullivan, D. I., Chun‐on, P., Morrell, M. R., McDyer, J. F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49072-9 · Cited by 7
Self-citationPulmonary fibrosis associated with telomere‐related gene mutations: A complex inheritance
Borie, R., & Renzoni, E. A. (2021) · Respirology · doi:10.1111/resp.14168 · Cited by 7
“This epigenetic-like inheritance in human telomerase disorders also explains the occurrence of phenocopy (affected patients without the familial mutation).(13,14) In a recent publication in Respirology, van der Vis et al.”
BackgroundPennington, K. M., Simonetto, D. A., Taner, T., & Mangaonkar, A. A. (2024) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-024-00724-z · Cited by 5
“Genetic mutations associated with shortened telomeres have also been identified in rheumatoid arthritis associated ILD, pleuroparenchymal fibroelastosis, hyper-sensitivity pneumonitis, and combined pulmonary fibrosis and emphysema [10, 11].”
Mechanisms and markers of lung ageing in health and disease
Miller, Z., Twardowski, L.-M., Reader, B. F., Rojas, M. M., Lehmann, M., & Mora, A. L. (2025) · European Respiratory Review · doi:10.1183/16000617.0233-2024 · Cited by 14
Telomeres in the Clinic, Not on TV
Armanios, M. Y. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.05.024 · Cited by 5
Self-citationMutairy, E. A., Qattan, S. M. A., Khalid, M., Al-Enazi, A. A., Al‐Saif, M., Imtiaz, F., Ramzan, K., Raveendran, V. V., Alaiya, A. A., Meyer, B. F., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1282868 · Cited by 5
Telomeropathies in Interstitial Lung Disease and Lung Transplant Recipients
Southern, B. D., & Gadre, S. K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051496 · Cited by 11
“This has been observed in families with pulmonary fibrosis carrying monoallelic variants of TERC, TERT, or other genes, resulting in early-onset pulmonary fibrosis and other disorders, such as bone marrow failure [39].”
The Function of Epithelial Cells in Pulmonary Fibrosis
Jia, S., & Kim, K. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803809-3.00007-5 · Cited by 7
Groen, K., van der Vis, J. J., van Batenburg, A. A., Kazemier, K. M., Grutters, J. C., & van Moorsel, C. H. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032790 · Cited by 5
Guérin, C., Crestani, B., Dupin, C., Kawano-Dourado, L. B., Ba, I., Kannengiesser, C., & Borie, R. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.03.011 · Cited by 5
Carlier, F. M., Planté-Bordeneuve, T., Froidure, A., Graux, C., van Dievoet, M., van Moorsel, C. H. M., & Hoffman, T. W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1718107 · Cited by 7
Genetics of Pulmonary Fibrosis
Adams, T. N., & Garcia, C. K. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_8 · Cited by 3
de Andrade, K. C., Pinto, E. M., Zhao, T., Zeigler, L. P., Kim, J., Giri, N., Haley, J. S., McReynolds, L. J., Flórez-Vargas, O., Phillips, A. H., et al. (2025) · npj Genomic Medicine · doi:10.1038/s41525-025-00501-8 · Cited by 2
“Nonetheless, defects in telomerase processivity have been shown to impact telomere length maintenance in vivo 17,18 .”
Metadata
- Authors
- Alder, J. K., Cogan, J. D., Brown, A. F., Anderson, C. J., Lawson, W. E., Lansdorp, P. M., Phillips, J. A., Loyd, J. E., Chen, J. J.-L., & Armanios, M.
- Affiliations
- Johns Hopkins University (US)
- Vanderbilt University (US)
- Arizona State University (US)
- University of British Columbia (CA)
- Corresponding author
- Armanios, Mary
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-03-31
- Volume
- 7
- Issue
- 3
- Pages
- e1001352
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3069110
- OpenAlex
- W2080657387
- Cited by
- 119
- References
- 46
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 5 · 2023: 7 · 2022: 9 · 2021: 7 · 2020: 7 · 2019: 7 · 2018: 12 · 2017: 6 · 2016: 8 · 2015: 4 · 2014: 12 · 2013: 9 · 2012: 8
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, other-oa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Science Foundation (0642857, CAREER)
- Doris Duke Charitable Foundation
- Vanderbilt University
- National Institutes of Health (HL092870)
- National Heart, Lung, and Blood Institute (K08HL085406, P01HL092870, T32HL094296)
- National Cancer Institute (K08CA118416, KO8 CA118416)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Keywords
- telomerase reverse transcriptase, hTERT, telomere maintenance, idiopathic pulmonary fibrosis, familial pulmonary fibrosis, germline mutations, founder mutation, haploinsufficiency, telomere shortening, loss-of-function mechanism, catalytic domain
- MeSH terms
- Adult, Aged, Female, Humans, Male, Middle Aged, Mutation, Pedigree, Pulmonary Fibrosis, Telomere, Telomerase, Catalytic Domain, Haploinsufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.